NCT06558175View on ClinicalTrials.gov

Reirradiation Dose Escalation in Thoracic Cancers

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 30, 2024

Primary Completion Date

October 30, 2026

Study Completion Date

January 29, 2027

Conditions
Thoracic CancerLung CancerEsophageal Cancer
Interventions
RADIATION

stereotactic body radiation therapy (SBRT)

Patients will be assigned to treatment doses using the TITE-CRM model.

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT06558175 - Reirradiation Dose Escalation in Thoracic Cancers | Biotech Hunter | Biotech Hunter